The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…
India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…
The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…
🔬 How CDSCO Monitors Drug Quality in India: Understanding NSQ Alerts, Factory Inspections & What International Buyers Should Know India is one of the world's largest producers of generic medicines,…